109 results
6-K
EX-99.1
SPRC
SciSparc Ltd
6 Jan 22
Report of Foreign Private Issuer
4:02pm
and special bonuses), as well as equity-based compensation, retirement and termination of employment arrangements and other benefits. The cash bonuses … officers may be granted with several cash and equity benefits upon or in connection with “Change of Control” or, where applicable, in the event
6-K
EX-99.1
SPRC
SciSparc Ltd
22 Dec 21
Report of Foreign Private Issuer
4:05pm
securities laws. For example, SciSparc is using forward-looking statements when it discusses the expected medical benefits of its therapeutics and drug … candidates, the expected benefits of becoming a company listed on Nasdaq. Because such statements deal with future events and are based on SciSparc’s
20-F/A
2023 FY
SPRC
SciSparc Ltd
2 May 24
Annual report (foreign) (amended)
9:18am
in their economic best interest.
Fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits … employee-benefit plans:
Short-term employee benefits:
Short-term employee benefits are benefits that are expected to be settled wholly before twelve
6-K
EX-99.1
fvcyge6d0mq
20 Dec 21
SciSparc Announces Approval of Uplisting to The Nasdaq Capital Market
4:45pm
6-K
EX-99.1
xr2tevw1w
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm
6-K
EX-99.1
r8x78q3wh2cmmbgy 57
2 Dec 20
Therapix Biosciences to Collaborate with The University of Calgary to Further Examine its Proprietary Drug Candidate THX-160 for Pain
9:25am
6-K
EX-99.1
j55blc 333gixicxi
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm
6-K
EX-99.2
dc4zmsbzm
22 Apr 20
Therapix Biosciences Announces Appointment of New CEO
5:30pm
6-K
EX-10.4
50ra 1ssa4qt8vna2urr
12 Oct 23
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
8:48am
20-F
t7sx9
1 May 17
Annual report (foreign)
12:00am
6-K
EX-99.4
95wmk8uh5
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
EX-99.1
b790h4wv5vprmk2
8 Dec 20
Therapix Biosciences Announces Upgrade to OTCQB Venture Market
9:36am
6-K
EX-99.3
oidu69bl4bcwqyxe
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.1
d5azzs7hx4msczkug0hm
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
6-K
EX-99.1
ydci ft3k
11 Apr 24
Agreement and Plan of Merger
4:05pm